Global Variome shared LOVD
B3GALT6 (beta-1,3-galactosyltransferase 6)
LOVD v.3.0 Build 29 [
Current LOVD status
]
Register as submitter
|
Log in
Curators:
Cynthia Silveira
and
Raymond Dalgleish
View all genes
View B3GALT6 gene homepage
View graphs about the B3GALT6 gene database
Create a new gene entry
View all transcripts
View all transcripts of gene B3GALT6
Create a new transcript information entry
View all variants
View all variants affecting transcripts
View unique variants in gene B3GALT6
View all variants in gene B3GALT6
Full data view for gene B3GALT6
Create a new data submission
View active genomic custom columns
Enable more genomic custom columns
View all individuals
View all individuals with variants in gene B3GALT6
Create a new data submission
View active custom columns
Enable more custom columns
View all diseases
View all diseases associated with gene B3GALT6
Create a new disease information entry
View available phenotype columns
View all screenings
View all screenings for gene B3GALT6
Create a new data submission
View active custom columns
Enable more custom columns
Submit new data
Full data view for gene B3GALT6
Ehlers Danlos Syndrome Variant Database
ADAMTS2 (ADAM metallopeptidase with thrombospondin type 1 motif 2)
AEBP1 (AE binding protein 1)
B3GALT6 (beta-1,3-galactosyltransferase 6)
B4GALT7 (beta-1,4-galactosyltransferase 7)
C1R (complement component 1, r subcomponent)
CHST14 (carbohydrate sulfotransferase 14)
COL1A1 (collagen type I alpha 1 chain)
COL1A2 (collagen type I alpha 2 chain)
COL3A1 (collagen type III alpha 1 chain)
COL5A1 (collagen type V alpha 1 chain)
COL5A2 (collagen type V alpha 2 chain)
DSE (dermatan sulfate epimerase)
FKBP14 (FKBP prolyl isomerase 14)
PLOD1 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 1)
PLOD3 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 3)
TNXB (tenascin XB)
The variants shown are described using the NM_080605.3 transcript reference sequence.
Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect
: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon
: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA)
: description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
RNA change
: description of variant at RNA level (following HGVS recommendations).
r.123c>u
r.? = unknown
r.(?) = RNA not analysed but probably transcribed copy of DNA variant
r.spl? = RNA not analysed but variant probably affects splicing
r.(spl?) = RNA not analysed but variant may affect splicing
r.0? = change expected to abolish transcription
Protein
: description of variant at protein level (following HGVS recommendations).
p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
p.Arg345Pro = change derived from RNA analysis
p.? = unknown effect
p.0? = probably no protein produced
Predicted
: predicted consequence of variant (RNA/protein level)
All options:
missense
nonsense
frameshift
no-stop
silent
splicing affected
splicing affected, exon skipped
splicing affected?
deletion
deletion, small
deletion, large
deletion, exon
deletion, multi exon
duplication
duplication, small
duplication, large
insertion
insertion, small
insertion, large
delins = insertion/deletion
conversion
other/complex
Type/DNA
: type of variant at DNA level. NOTE: can be derived automatically from the variant description (for all levels)
All options:
substitution
deletion
deletion, small
deletion, large
duplication
duplication, small
duplication, large
insertion
insertion, small
insertion, large
delins = insertion/deletion
inversion
conversion
transposition
translocation
other/complex
Allele
: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Classification method
: The method used for the clinical classification of this variant.
All options:
ACMG
ACGS
EAHAD-CFDB
ENIGMA
IARC
InSiGHT
kConFab
other
Clinical classification
: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
pathogenic
pathogenic (dominant)
pathogenic (recessive)
pathogenic (!)
pathogenic (maternal)
pathogenic (paternal)
likely pathogenic
likely pathogenic (dominant)
likely pathogenic (recessive)
likely pathogenic (!)
likely pathogenic (maternal)
likely pathogenic (paternal)
VUS
VUS (!)
likely benign
likely benign (dominant)
likely benign (recessive)
likely benign (!)
likely benign (maternal)
likely benign (paternal)
benign
benign (dominant)
benign (recessive)
benign (!)
benign (maternal)
benign (paternal)
association
unclassified
NA
DNA change (genomic) (hg19)
: HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38)
: HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as
: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN
: description of the variant according to ISCN nomenclature
DB-ID
: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks
: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference
: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID
: ID of variant in ClinVar database
dbSNP ID
: the dbSNP ID
Origin
: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
Germline
De novo
Germline/De novo (untested)
Somatic
Uniparental disomy
Uniparental disomy, maternal allele
Uniparental disomy, paternal allele
CLASSIFICATION record
SUMMARY record
In vitro (cloned)
In silico
animal model
Artefact
DUPLICATE record
Unknown
Not applicable
Segregation
: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
? = unknown
yes = segregates with phenotype
no = does not segregate with phenotype
- = not applicable
Frequency
: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site
: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP
: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.
Methylation
: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)
Template
: Template(s) used to detect the sequence variant; DNA (genomic DNA), RNA (cDNA) or protein
All options:
DNA
RNA = RNA (cDNA)
protein
? = unknown
Technique
: technique(s) used to identify the sequence variant.
All options:
? = unknown
ARMS = amplification refractory mutation system
arrayCGH = array for Comparative Genomic Hybridisation
arraySEQ = array for resequencing
arraySNP = array for SNP typing
arrayCNV = array for Copy Number Variation (SNP and CNV probes)
ASO = allele-specific oligo hybridisation
BESS = Base Excision Sequence Scanning
CMC = Chemical Mismatch Cleavage
COBRA = Combined Bisulfite Restriction Analysis
CSCE = Conformation Sensitive Capillary Electrophoresis
CSGE = Conformation Sensitive Gel Electrophoresis
ddF = dideoxy Fingerprinting
DGGE = Denaturing-Gradient Gel-Electrophoresis
DHPLC = Denaturing High-Performance Liquid Chromatography
DOVAM = Detection Of Virtually All Mutations (SSCA variant)
DSCA = Double-Strand DNA Conformation Analysis
DSDI = Detection Small Deletions and Insertions
EMC = Enzymatic Mismatch Cleavage
expr = expression analysis
FISH = Fluorescent In-Situ Hybridisation
FISHf = fiberFISH
HD = HeteroDuplex analysis
HPLC = High-Performance Liquid Chromatography
IEF = IsoElectric Focussing
IHC = Immuno-Histo-Chemistry
Invader = Invader assay
MAPH = Multiplex Amplifiable Probe Hybridisation
MAQ = Multiplex Amplicon Quantification
MCA = Melting Curve Analysis, high-resolution (HRMA)
microscope = microscopic analysis (karyotype)
microsat = microsatellite genotyping
minigene = expression minigene construct
MIP = Molecular Inversion Probe amplification
MIPsm = singele molecule Molecular Inversion Probe amplification
MLPA = Multiplex Ligation-dependent Probe Amplification
MLPA-ms = Multiplex Ligation-dependent Probe Amplification, methylation specific
MS = mass spectrometry
Northern = Northern blotting
NUC = nuclease digestion (RNAseT1, S1)
OM = optical mapping
PAGE = Poly-Acrylamide Gel-Electrophoresis
PCR = Polymerase Chain Reaction
PCRdd = PCR, digital droplet
PCRdig = PCR + restriction enzyme digestion
PCRh = PCR, haloplex
PCRlr = PCR, long-range
PCRm = PCR, multiplex
PCRms = PCR, methylation sensitive
PCRq = PCR, quantitative (qPCR)
PCRrp = PCR, repeat-primed (RP-PCR)
PCRsqd = PCR, semi-quantitative duplex
PE = primer extension (APEX, SNaPshot)
PEms = primer extension, methylation-sensitive single-nucleotide
PFGE = Pulsed-Field Gel-Electrophoresis (+Southern)
PTT = Protein Truncation Test
RFLP = Restriction Fragment Length Polymorphisms
RT-PCR = Reverse Transcription and PCR
RT-PCRq = Reverse Transcription and PCR, quantitative
SBE = Single Base Extension
SEQ = SEQuencing (Sanger)
SEQb = bisulfite SEQuencing
SEQp = pyroSequencing
SEQms = sequencing, methylation specific
SEQ-ON = next-generation sequencing - Oxford Nanopore
SEQ-NG = next-generation sequencing
SEQ-NG-RNA = next-generation sequencing RNA
SEQ-NG-H = next-generation sequencing - Helicos
SEQ-NG-I = next-generation sequencing - Illumina/Solexa
SEQ-NG-IT = next-generation sequencing - Ion Torrent
SEQ-NG-R = next-generation sequencing - Roche/454
SEQ-NG-S = next-generation sequencing - SOLiD
SEQ-PB = next-generation sequencing - Pacific Biosciences
SNPlex = SNPlex
Southern = Southern blotting
SSCA = Single-Strand DNA Conformation polymorphism Analysis (SSCP)
SSCAf = fluorescent SSCA (SSCP)
STR = Short Tandem Repeat
TaqMan = TaqMan assay
Western = Western blotting
- = not applicable
Tissue
: tissue type used for analysis
Remarks
: remarks regarding the screening like WGS (whole genome sequencing), WES (whole exome sequencing, gene panel (incl. a list of genes analysed), etc.
ID_report
: ID of the individual that can be publically shared, e.g. as listed in a publication
Reference
: reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, incl. link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
Remarks
: remarks about the individual
Gender
: gender individual
All options:
? = unknown
- = not applicable
F = female
M = male
rF = raised as female
rM = raised as male
Consanguinity
: indicates whether the parents are related (consanguineous), not related (non-consanguineous) or whether consanguinity is not known (unknown)
All options:
no = non-consanguineous parents
yes = consanguineous parents
likely = consanguinity likely
? = unknown
- = not applicable
Country
: where (country) does the individual live/recently came from. Give additional details (population, specific sub-group) and when parents come from different countries in "Population". Belgium = individual lives in/recently came from Belgium, (France) = reported by laboratory in France, individual's country of origin not sure
All options:
? (unknown)
- (not applicable)
Afghanistan
(Afghanistan)
Albania
(Albania)
Algeria
(Algeria)
American Samoa
(American Samoa)
Andorra
(Andorra)
Angola
(Angola)
Anguilla
(Anguilla)
Antarctica
(Antarctica)
Antigua and Barbuda
(Antigua and Barbuda)
Argentina
(Argentina)
Armenia
(Armenia)
Aruba
(Aruba)
Australia
(Australia)
Austria
(Austria)
Azerbaijan
(Azerbaijan)
Bahamas
(Bahamas)
Bahrain
(Bahrain)
Bangladesh
(Bangladesh)
Barbados
(Barbados)
Belarus
(Belarus)
Belgium
(Belgium)
Belize
(Belize)
Benin
(Benin)
Bermuda
(Bermuda)
Bhutan
(Bhutan)
Bolivia
(Bolivia)
Bosnia and Herzegovina
(Bosnia and Herzegovina)
Botswana
(Botswana)
Bouvet Island
(Bouvet Island)
Brazil
(Brazil)
British Indian Ocean Territory
(British Indian Ocean Territory)
Brunei Darussalam
(Brunei Darussalam)
Bulgaria
(Bulgaria)
Burkina Faso
(Burkina Faso)
Burundi
(Burundi)
Cambodia
(Cambodia)
Cameroon
(Cameroon)
Canada
(Canada)
Cape Verde
(Cape Verde)
Cayman Islands
(Cayman Islands)
Central African Republic
(Central African Republic)
Central Europe
Chad
(Chad)
Chile
(Chile)
China
(China)
Christmas Island
(Christmas Island)
Cocos (Keeling Islands)
(Cocos (Keeling Islands))
Colombia
(Colombia)
Comoros
(Comoros)
Congo
(Congo)
Cook Islands
(Cook Islands)
Costa Rica
(Costa Rica)
Cote D'Ivoire (Ivory Coast)
(Cote D'Ivoire (Ivory Coast))
Croatia (Hrvatska)
(Croatia (Hrvatska))
Cuba
(Cuba)
Cyprus
(Cyprus)
Czech Republic
(Czech Republic)
Denmark
(Denmark)
Djibouti
(Djibouti)
Dominica
(Dominica)
Dominican Republic
(Dominican Republic)
East Timor
(East Timor)
Ecuador
(Ecuador)
Egypt
(Egypt)
El Salvador
(El Salvador)
England
(England)
Equatorial Guinea
(Equatorial Guinea)
Eritrea
(Eritrea)
Estonia
(Estonia)
Ethiopia
(Ethiopia)
Falkland Islands (Malvinas)
(Falkland Islands (Malvinas))
Faroe Islands
(Faroe Islands)
Fiji
(Fiji)
Finland
(Finland)
France
(France)
Gabon
(Gabon)
Gambia
(Gambia)
Georgia
(Georgia)
Germany
(Germany)
Ghana
(Ghana)
Gibraltar
(Gibraltar)
Greece
(Greece)
Greenland
(Greenland)
Grenada
(Grenada)
Guadeloupe
(Guadeloupe)
Guam
(Guam)
Guatemala
(Guatemala)
Guiana, French
(Guiana, French)
Guinea
(Guinea)
Guinea-Bissau
(Guinea-Bissau)
Guyana
(Guyana)
Haiti
(Haiti)
Heard and McDonald Islands
(Heard and McDonald Islands)
Honduras
(Honduras)
Hong Kong
(Hong Kong)
Hungary
(Hungary)
Iceland
(Iceland)
India
(India)
Indonesia
(Indonesia)
Iran
(Iran)
Iraq
(Iraq)
Ireland
(Ireland)
Israel
(Israel)
Italy
(Italy)
Jamaica
(Jamaica)
Japan
(Japan)
Jordan
(Jordan)
Kazakhstan
(Kazakhstan)
Kenya
(Kenya)
Kiribati
(Kiribati)
Korea
(Korea)
Korea, North (People's Republic)
(Korea, North (People's Republic))
Korea, South (Republic)
(Korea, South (Republic))
Kosovo
(Kosovo)
Kuwait
(Kuwait)
Kyrgyzstan (Kyrgyz Republic)
(Kyrgyzstan (Kyrgyz Republic))
Laos
(Laos)
Latvia
(Latvia)
Lebanon
(Lebanon)
Lesotho
(Lesotho)
Liberia
(Liberia)
Libya
(Libya)
Liechtenstein
(Liechtenstein)
Lithuania
(Lithuania)
Luxembourg
(Luxembourg)
Macau
(Macau)
Macedonia
(Macedonia)
Madagascar
(Madagascar)
Malawi
(Malawi)
Malaysia
(Malaysia)
Maldives
(Maldives)
Mali
(Mali)
Mallorca
(Mallorca)
Malta
(Malta)
Marshall Islands
(Marshall Islands)
Martinique
(Martinique)
Mauritania
(Mauritania)
Mauritius
(Mauritius)
Mayotte
(Mayotte)
Mexico
(Mexico)
Micronesia
(Micronesia)
Moldova
(Moldova)
Monaco
(Monaco)
Mongolia
(Mongolia)
Montserrat
(Montserrat)
Morocco
(Morocco)
Mozambique
(Mozambique)
Myanmar
(Myanmar)
Namibia
(Namibia)
Nauru
(Nauru)
Nepal
(Nepal)
Netherlands
(Netherlands)
Netherlands Antilles
(Netherlands Antilles)
Neutral Zone (Saudia Arabia/Iraq)
(Neutral Zone (Saudia Arabia/Iraq))
New Caledonia
(New Caledonia)
New Zealand
(New Zealand)
Nicaragua
(Nicaragua)
Niger
(Niger)
Nigeria
(Nigeria)
Niue
(Niue)
Norfolk Island
(Norfolk Island)
Northern Ireland
(Northern Ireland)
Northern Mariana Islands
(Northern Mariana Islands)
Norway
(Norway)
Oman
(Oman)
Pakistan
(Pakistan)
Palau
(Palau)
Palestine
(Palestine)
Panama
(Panama)
Papua New Guinea
(Papua New Guinea)
Paraguay
(Paraguay)
Peru
(Peru)
Philippines
(Philippines)
Pitcairn
(Pitcairn)
Poland
(Poland)
Polynesia, French
(Polynesia, French)
Portugal
(Portugal)
Puerto Rico
(Puerto Rico)
Qatar
(Qatar)
Reunion
(Reunion)
Romania
(Romania)
Russia
(Russia)
Russian Federation
(Russian Federation)
Rwanda
(Rwanda)
S. Georgia and S. Sandwich Isls.
(S. Georgia and S. Sandwich Isls.)
Saint Kitts and Nevis
(Saint Kitts and Nevis)
Saint Lucia
(Saint Lucia)
Saint Vincent and The Grenadines
(Saint Vincent and The Grenadines)
Samoa
(Samoa)
San Marino
(San Marino)
Sao Tome and Principe
(Sao Tome and Principe)
Saudi Arabia
(Saudi Arabia)
Scotland
(Scotland)
Senegal
(Senegal)
Serbia
(Serbia)
Seychelles
(Seychelles)
Sierra Leone
(Sierra Leone)
Singapore
(Singapore)
Slovakia (Slovak Republic)
(Slovakia (Slovak Republic))
Slovenia
(Slovenia)
Solomon Islands
(Solomon Islands)
Somalia
(Somalia)
South Africa
(South Africa)
Southern Territories, French
(Southern Territories, French)
Soviet Union (former)
(Soviet Union (former))
Spain
(Spain)
Sri Lanka
(Sri Lanka)
St. Helena, Ascension and Tristan da
Cunha
(St. Helena, Ascension and Tristan da
Cunha)
St. Pierre and Miquelon
(St. Pierre and Miquelon)
Sudan
(Sudan)
Sudan, South
(Sudan, South)
Suriname
(Suriname)
Svalbard and Jan Mayen Islands
(Svalbard and Jan Mayen Islands)
Swaziland
(Swaziland)
Sweden
(Sweden)
Switzerland
(Switzerland)
Syria
(Syria)
Taiwan
(Taiwan)
Tajikistan
(Tajikistan)
Tanzania
(Tanzania)
Thailand
(Thailand)
Togo
(Togo)
Tokelau
(Tokelau)
Tonga
(Tonga)
Trinidad and Tobago
(Trinidad and Tobago)
Tunisia
(Tunisia)
Turkey
(Turkey)
Turkmenistan
(Turkmenistan)
Turks and Caicos Islands
(Turks and Caicos Islands)
Tuvalu
(Tuvalu)
Uganda
(Uganda)
Ukraine
(Ukraine)
United Arab Emirates
(United Arab Emirates)
United Kingdom (Great Britain)
(United Kingdom (Great Britain))
United States
(United States)
Uruguay
(Uruguay)
US Minor Outlying Islands
(US Minor Outlying Islands)
Uzbekistan
(Uzbekistan)
Vanuatu
(Vanuatu)
Vatican City State (Holy See)
(Vatican City State (Holy See))
Venezuela
(Venezuela)
Viet Nam
(Viet Nam)
Virgin Islands (British)
(Virgin Islands (British))
Virgin Islands (US)
(Virgin Islands (US))
Wales
(Wales)
Wallis and Futuna Islands
(Wallis and Futuna Islands)
Western Sahara
(Western Sahara)
Yemen
(Yemen)
Yugoslavia
(Yugoslavia)
Zaire
(Zaire)
Zambia
(Zambia)
Zimbabwe
(Zimbabwe)
Population
: population the individual (or ancestors) belongs to; e.g. white, gypsy, Jewish-Ashkenazi, Africa-N, Sardinia, etc.
Age at death
: age at which the individual deceased (when applicable):
35y = 35 years
>43y = still alive at 43y
04y08m = 4 years and 8 months
00y00m01d12h = 1 day and 12 hours
18y? = around 18 years
30y-40y = between 30 and 40 years
>54y = older than 54
? = unknown
VIP
: individual/phenotype VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.
Data_av
: are additional data available upon request: e.g. pedigree (yes/no/?)
Treatment
: treatment of patient
How to query this table
All list views have search fields which can be used to search data. You can search for a complete word or you can search for a part of a search term. If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify. Note that search terms are case-insensitive and that wildcards such as * are treated as normal text! For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.
Operator
Column type
Example
Matches
Text
Arg
all entries containing 'Arg'
space
Text
Arg Ser
all entries containing 'Arg' and 'Ser'
|
Text
Arg|Ser
all entries containing 'Arg' or 'Ser'
!
Text
!fs
all entries not containing 'fs'
^
Text
^p.(Arg
all entries beginning with 'p.(Arg'
$
Text
Ser)$
all entries ending with 'Ser)'
=""
Text
=""
all entries with this field empty
=""
Text
="p.0"
all entries exactly matching 'p.0'
!=""
Text
!=""
all entries with this field not empty
!=""
Text
!="p.0"
all entries not exactly matching 'p.0?'
combination
Text
*|Ter !fs
all entries containing '*' or 'Ter' but not containing 'fs'
Date
2020
all entries matching the year 2020
|
Date
2020-03|2020-04
all entries matching March or April, 2020
!
Date
!2020-03
all entries not matching March, 2020
<
Date
<2020
all entries before the year 2020
<=
Date
<=2020-06
all entries in or before June, 2020
>
Date
>2020-06
all entries after June, 2020
>=
Date
>=2020-06-15
all entries on or after June 15th, 2020
combination
Date
2019|2020 <2020-03
all entries in 2019 or 2020, and before March, 2020
Numeric
23
all entries exactly matching 23
|
Numeric
23|24
all entries exactly matching 23 or 24
!
Numeric
!23
all entries not exactly matching 23
<
Numeric
<23
all entries lower than 23
<=
Numeric
<=23
all entries lower than, or equal to, 23
>
Numeric
>23
all entries higher than 23
>=
Numeric
>=23
all entries higher than, or equal to, 23
combination
Numeric
>=20 <30 !23
all entries with values from 20 to 29, but not equal to 23
Some more advanced examples:
Example
Matches
Asian
all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc.
Asian !Caucasian
all entries containing 'Asian' but not containing 'Caucasian'
Asian|African !Caucasian
all entries containing 'Asian' or 'African', but not containing 'Caucasian'
"South Asian"
all entries containing 'South Asian', but not containing 'South East Asian'
To sort on a certain column, click on the column header or on the arrows. If that column is already selected to sort on, the sort order will be swapped. The column currently sorted on has a darker blue background color than the other columns. The up and down arrows next to the column name indicate the current sorting direction. When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.
101 entries on 2 pages. Showing entries 1 - 100.
10 per page
25 per page
50 per page
100 per page
250 per page
500 per page
1000 per page
Legend
How to query
« First
Prev
1
2
Next
Last »
Effect
Exon
DNA change (cDNA)
RNA change
Protein
Predicted
Type/DNA
Allele
Classification method
Clinical classification
DNA change (genomic) (hg19)
DNA change (hg38)
Published as
ISCN
DB-ID
Variant remarks
Reference
ClinVar ID
dbSNP ID
Origin
Segregation
Frequency
Re-site
VIP
Methylation
Template
Technique
Tissue
Remarks
Disease
ID_report
Reference
Remarks
Gender
Consanguinity
Country
Population
Age at death
VIP
Data_av
Treatment
Panel size
Owner
?/.
-
c.-3575_-3573del
r.(?)
p.(=)
-
-
Unknown
-
VUS
g.1164084_1164086del
g.1228704_1228706del
SDF4(NM_016176.3):c.90_92del (p.(Leu31del))
-
B3GALT6_000052
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+?/+?
1
c.1A>G
r.(?)
p.0?
initiating methionine
substitution
Parent #1
-
likely pathogenic
g.1167659A>G
-
-
-
B3GALT6_000028
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
Patient 1
PubMed: Nakajima et al., 2013
The patient had a sibling who was also compound heterozygous for both variants and had a similar phenotype.c.1A>G showed a decreased molecular weight ~4kD lower compared to the WT protein. The authors suggested that the translation initiation at the second ATG of the coding sequence (position c.124) would become the initiation codon, resulting in a protein change of p.Met1_Ala41del.The technique used was whole exome sequencing.
-
-
Japan
Japanese
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.1A>G
r.(?)
p.0?
initiating methionine
substitution
Parent #1
-
likely pathogenic
g.1167659A>G
-
-
-
B3GALT6_000028
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
Patient 3
PubMed: Nakajima et al., 2013
The authors predicted the c.1A>G variant would cause a 41 amino acid deletion due to the second ATG becoming the initiating codon. The technique used was whole exome sequencing.
-
-
Japan
Japanese
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.1A>G
r.(?)
p.0?
initiating methionine
substitution
Unknown
-
likely pathogenic
g.1167659A>G
-
-
-
B3GALT6_000028
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
P4
PubMed: Nakajima et al., 2013
The authors predicted the c.1A>G variant would result in a 41aa deletion due to the second ATG being the initiation codon.
-
-
Japan
Japanese
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.1A>G
r.(?)
p.0?
initiating methionine
substitution
Parent #1
-
likely pathogenic
g.1167659A>G
-
-
-
B3GALT6_000028
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
P5
PubMed: Nakajima et al., 2013
The authors predicted the c.1A>G variant would result in a 41 aa deletion due to the second ATG becoming the initiating codon. The technique used was whole exome sequencing.
-
-
Japan
Japanese
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.1A>G
r.(?)
p.0?
initiating methionine
substitution
Parent #1
-
likely pathogenic
g.1167659A>G
-
-
-
B3GALT6_000028
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
P7
PubMed: Nakajima et al., 2013
The authors predicted the c.1A>G variant would result in a 41aa deletion due to the second ATG becoming the initiating codon. The technique used was whole exome sequencing.
-
-
Japan;Singapore
Japanese/Singaporean
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.3G>A
r.(?)
p.0?
initiating methionine
substitution
Unknown
-
pathogenic
g.1167661G>A
-
-
-
B3GALT6_000016
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
-
-
-
India
Indian
-
-
-
-
1
Sofie Symoens
+?/+?
1
c.16C>T
r.(?)
p.(Arg6Trp)
-
-
Unknown
-
pathogenic (recessive)
g.1167674C>T
g.1232294C>T
-
-
B3GALT6_000007
-
-
-
-
Unknown
yes
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+?
1
c.16C>T
r.(?)
p.(Arg6Trp)
missense
substitution
Parent #1
-
likely pathogenic
g.1167674C>T
-
-
-
B3GALT6_000007
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
EDS, EDSSPD1
P12
PubMed: Nakajima et al., 2013
-
-
-
Brazil
-
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.16C>T
r.(?)
p.(Arg6Trp)
missense
substitution
Unknown
-
likely pathogenic
g.1167674C>T
-
-
-
B3GALT6_000007
-
PubMed: Vorster et al., 2014
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
F1
PubMed: Vorster et al., 2014
The patient had an unaffected sibling who only carried the c.16C>T variant.
-
-
South Africa
Afrikaner
-
-
-
-
1
Raymond Dalgleish
-?/.
-
c.17G>A
r.(?)
p.(Arg6Gln)
-
-
Unknown
-
likely benign
g.1167675G>A
-
B3GALT6(NM_080605.4):c.17G>A (p.R6Q)
-
B3GALT6_000063
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-?/.
-
c.22_36dup
r.(?)
p.(Trp8_Ala12dup)
-
-
Unknown
-
likely benign
g.1167680_1167694dup
-
B3GALT6(NM_080605.4):c.22_36dupTGGCGGCGGCGGGCG (p.W8_A12dup)
-
B3GALT6_000059
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
1
c.77T>C
r.(?)
p.(Leu26Pro)
missense
substitution
Unknown
-
pathogenic
g.1167735T>C
-
-
-
B3GALT6_000020
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
The technique used was the custom NGS Gene panel.
-
-
France
French
-
-
-
-
1
Sofie Symoens
?/.
-
c.181G>C
r.(?)
p.(Val61Leu)
-
-
Unknown
-
VUS
g.1167839G>C
g.1232459G>C
-
-
B3GALT6_000022
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
1
c.181G>C
r.(?)
p.(Val61Leu)
missense
substitution
Unknown
-
pathogenic
g.1167839G>C
-
-
-
B3GALT6_000022
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
A non-consanguineous couple of Caucasian origin had two pregnancies terminated because of severe skeletal dysplasia. The second pregnancy was assigned the Patient ID AN_005849.The technique used was whole exome sequencing.
-
-
Netherlands
Dutch
-
-
-
-
1
Sofie Symoens
+?/.
1
c.182T>C
r.(?)
p.(Val61Ala)
-
-
Paternal (confirmed)
-
likely pathogenic
g.1167840T>C
g.1232460T>C
-
-
B3GALT6_000041
-
-
-
-
Germline
yes
-
-
-
-
DNA
PCR
Blood
-
SEMDJL1
-
-
-
M
no
-
-
-
-
-
-
1
Cynthia Silveira
+?/+?
1
c.193A>G
r.(?)
p.(Ser65Gly)
missense
substitution
Parent #2
-
likely pathogenic
g.1167851A>G
-
-
-
B3GALT6_000032
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
P7
PubMed: Nakajima et al., 2013
The authors predicted the c.1A>G variant would result in a 41aa deletion due to the second ATG becoming the initiating codon. The technique used was whole exome sequencing.
-
-
Japan;Singapore
Japanese/Singaporean
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.197_253del
r.(?)
p.(Ala66_Arg84del)
deletion
deletion
Unknown
-
pathogenic
g.1167855_1167911del
-
-
-
B3GALT6_000014
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
This patient (PIV:1) has two affected siblings with IDs AN_005842 and AN_005843.
-
-
Congo;Rwanda
Congolese-Rwandan
-
-
-
-
1
Sofie Symoens
+?/+?
1
c.200C>T
r.(?)
p.(Pro67Leu)
missense
substitution
Parent #2
-
likely pathogenic
g.1167858C>T
-
-
-
B3GALT6_000033
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
P8
PubMed: Nakajima et al., 2013
-
-
-
Viet Nam
Vietnamese
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.200C>T
r.(?)
p.(Pro67Leu)
missense
substitution
Paternal (confirmed)
-
likely pathogenic
g.1167858C>T
-
-
-
B3GALT6_000033
-
PubMed: Honey et al., 2016
-
-
Unknown
-
-
-
-
-
DNA
?
-
-
SEMDJL1
Family 1
PubMed: Honey et al., 2016
The patient had a brother who was also positive for both variants, and had a similar phenotype.
-
-
South Africa
Afrikaner
-
-
-
-
1
Raymond Dalgleish
+/+?
1
c.200C>T
r.(?)
p.(Pro67Leu)
missense
substitution
Maternal (confirmed)
-
likely pathogenic
g.1167858C>T
-
-
-
B3GALT6_000033
-
PubMed: Honey et al., 2016
-
-
Unknown
-
-
-
-
-
DNA
?
-
-
SEMDJL1
Family 2
PubMed: Honey et al., 2016
-
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.200C>T
r.(?)
p.(Pro67Leu)
missense
substitution
Unknown
-
likely pathogenic
g.1167858C>T
-
-
-
B3GALT6_000033
-
PubMed: Vorster et al., 2014
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
F1
PubMed: Vorster et al., 2014
The patient had an unaffected sibling who only carried the c.16C>T variant.
-
-
South Africa
Afrikaner
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.227del
r.(?)
p.(Ile76Thrfs*202)
frameshift
deletion
Maternal (confirmed)
-
pathogenic
g.1167885del
-
-
-
B3GALT6_000037
-
PubMed: Ritelli et al., 2015
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG, SEQ
-
-
SEMDJL1
Patient 1
PubMed: Ritelli et al., 2015
The patient had a younger sister who carried both variants and had a similar phenotype. The technique used was the custom NGS Gene panel.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.235A>G
r.(?)
p.(Thr79Ala)
missense
substitution
Maternal (inferred)
-
likely pathogenic
g.1167893A>G
-
-
-
B3GALT6_000034
-
PubMed: Honey et al., 2016
-
-
Unknown
-
-
-
-
-
DNA
?
-
-
SEMDJL1
Family 1
PubMed: Honey et al., 2016
The patient had a brother who was also positive for both variants, and had a similar phenotype.
-
-
South Africa
Afrikaner
-
-
-
-
1
Raymond Dalgleish
+/+?
1
c.235A>G
r.(?)
p.(Thr79Ala)
missense
substitution
Paternal (confirmed)
-
likely pathogenic
g.1167893A>G
-
-
-
B3GALT6_000034
-
PubMed: Honey et al., 2016
-
-
Unknown
-
-
-
-
-
DNA
?
-
-
SEMDJL1
Family 2
PubMed: Honey et al., 2016
-
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.235A>G
r.(?)
p.(Thr79Ala)
missense
substitution
Both (homozygous)
-
likely pathogenic
g.1167893A>G
-
-
-
B3GALT6_000034
-
PubMed: Vorster et al., 2014
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
F3
PubMed: Vorster et al., 2014
-
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.235A>G
r.(?)
p.(Thr79Ala)
missense
substitution
Both (homozygous)
-
likely pathogenic
g.1167893A>G
-
-
-
B3GALT6_000034
-
PubMed: Vorster et al., 2014
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
F8
PubMed: Vorster et al., 2014
One unaffected parent's B3GALT6 gene was sequenced and shown to be heterozygous for c.235A>G.
-
-
South Africa
Afrikaner
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.235A>G
r.(?)
p.(Thr79Ala)
missense
substitution
Both (homozygous)
-
likely pathogenic
g.1167893A>G
-
-
-
B3GALT6_000034
-
PubMed: Vorster et al., 2014
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
F10
PubMed: Vorster et al., 2014
-
-
-
South Africa
Afrikaner
-
-
-
-
1
Raymond Dalgleish
-/-
1
c.308C>T
r.(?)
p.(Ala103Val)
missense
substitution
Paternal (confirmed)
-
likely benign
g.1167966C>T
-
-
-
B3GALT6_000026
-
PubMed: Caraffi et al., 2019
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG, PCR, SEQ
-
-
EDS, EDSSPD1
Patient 3
PubMed: Caraffi et al., 2019
The patient was the second child of non-consanguineous parents. Three variants were detected, and variant c.308C>T was described as a variant of uncertain significance. The technique used was the custom NGS Gene panel.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.323_344del
r.(?)
p.(Ala108Glyfs∗163)
nonsense
deletion
Parent #1
-
pathogenic
g.1167981_1168002del
-
-
-
B3GALT6_000002
-
PubMed: Malfait et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
RT-PCR, SEQ
-
-
EDS, EDSSPD2
P3
PubMed: Malfait et al., 2013
Has a younger sister, P4, of the same genotype
-
-
Iran
-
-
-
-
-
1
Raymond Dalgleish
-?/.
-
c.324C>A
r.(?)
p.(Ala108=)
-
-
Unknown
-
likely benign
g.1167982C>A
g.1232602C>A
B3GALT6(NM_080605.4):c.324C>A (p.A108=)
-
B3GALT6_000053
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
1
c.353del
r.(?)
p.(Asp118Alafs*160)
nonsense
deletion
Parent #1
-
pathogenic
g.1168011del
-
-
-
B3GALT6_000004
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
EDS, EDSSPD1
P9
PubMed: Nakajima et al., 2013
This patient was further described in {PMID31614862:Caraffi et al., 2019}
-
-
Italy
Italy
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.353del
r.(?)
p.(Asp118Alafs*160)
nonsense
deletion
Paternal (confirmed)
-
pathogenic
g.1168011del
-
-
-
B3GALT6_000004
-
PubMed: Caraffi et al., 2019
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG, PCR, SEQ
-
-
EDS, EDSSPD1
Patient 3
PubMed: Caraffi et al., 2019
The patient was the second child of non-consanguineous parents. Three variants were detected, and variant c.308C>T was described as a variant of uncertain significance. The technique used was the custom NGS Gene panel.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
?/.
-
c.381C>G
r.(?)
p.(Asp127Glu)
-
-
Unknown
-
VUS
g.1168039C>G
-
B3GALT6(NM_080605.4):c.381C>G (p.D127E)
-
B3GALT6_000060
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+?
1
c.415_423del
r.(?)
p.(Met139Ala141del)
deletion
deletion
Parent #2
-
likely pathogenic
g.1168073_1168081del
-
-
-
B3GALT6_000008
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
EDS, EDSSPD1
P12
PubMed: Nakajima et al., 2013
-
-
-
Brazil
-
-
-
-
-
1
Raymond Dalgleish
?/.
-
c.426G>T
r.(?)
p.(Trp142Cys)
-
-
Unknown
-
VUS
g.1168084G>T
-
-
-
B3GALT6_000067
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
?/.
-
c.430G>A
r.(?)
p.(Asp144Asn)
-
-
Unknown
-
VUS
g.1168088G>A
g.1232708G>A
-
-
B3GALT6_000018
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
1
c.430G>A
r.(?)
p.(Asp144Asn)
missense
substitution
Unknown
-
pathogenic
g.1168088G>A
-
-
-
B3GALT6_000018
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
-
-
-
Netherlands
Dutch
-
-
-
-
1
Sofie Symoens
+?/+?
1
c.466G>A
r.(?)
p.(Asp156Asn)
missense
substitution
Parent #2
-
likely pathogenic
g.1168124G>A
-
-
-
B3GALT6_000030
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
Patient 3
PubMed: Nakajima et al., 2013
The authors predicted the c.1A>G variant would cause a 41 amino acid deletion due to the second ATG becoming the initiating codon. The technique used was whole exome sequencing.
-
-
Japan
Japanese
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.476C>A
r.(?)
p.(Ser159Tyr)
missense
substitution
Maternal (confirmed)
-
pathogenic
g.1168134C>A
-
-
-
B3GALT6_000024
-
PubMed: Sellars et al., 2014
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Sellars et al., 2014
The authors have confirmed the transcript-level sequence variants that cause the amino acid substitutions.The technique used was whole exome sequencing.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
-?/.
-
c.477C>T
r.(?)
p.(Ser159=)
-
-
Unknown
-
likely benign
g.1168135C>T
-
B3GALT6(NM_080605.4):c.477C>T (p.S159=)
-
B3GALT6_000064
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
1
c.477del
r.(?)
p.(Phe160Serfs*118)
frameshift
deletion
Unknown
-
pathogenic
g.1168135del
-
-
-
B3GALT6_000012
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
-
-
-
Netherlands
Dutch
-
-
-
-
1
Sofie Symoens
-?/.
-
c.483G>A
r.(?)
p.(Ala161=)
-
-
Unknown
-
likely benign
g.1168141G>A
-
B3GALT6(NM_080605.4):c.483G>A (p.A161=)
-
B3GALT6_000061
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-?/.
-
c.483G>A
r.(?)
p.(Ala161=)
-
-
Unknown
-
likely benign
g.1168141G>A
-
B3GALT6(NM_080605.4):c.483G>A (p.A161=)
-
B3GALT6_000061
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+?/+
-
c.510_517del
r.(?)
p.(Glu174Alafs*266)
frameshift
deletion
Paternal (inferred)
ACMG
likely pathogenic
g.1168168_1168175del
g.1232791_1232798del
-
-
B3GALT6_000065
-
PubMed: Shen et al., 2022
-
-
Germline
-
-
-
-
-
DNA
SEQ-NG-I
peripheral blood
-
EDSSPD
I-1
PubMed: Shen et al., 2022
-
M
no
China
-
-
-
-
-
1
Oumaima Nehaili
+?/.
-
c.510_517del
r.(?)
p.(Glu174Alafs*266)
deletion
deletion
Paternal (confirmed)
ACMG
likely pathogenic
g.1168168_1168175del
g.1232791_1232798del
-
-
B3GALT6_000065
-
PubMed: Shen et al., 2022
-
-
Germline
-
-
-
-
-
DNA
SEQ-NG-I
Peripheral blood
-
EDSSPD
III-2
PubMed: Shen et al., 2022
-
M
no
China
-
-
-
-
-
1
Oumaima Nehaili
+?/+?
1
c.511C>T
r.(?)
p.(Arg171Cys)
missense
substitution
Paternal (confirmed)
-
likely pathogenic
g.1168169C>T
-
-
-
B3GALT6_000036
-
PubMed: Trejo et al., 2017
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
IV-5
PubMed: Trejo et al., 2017
The proband also had two siblings who carried both variants in B3GALT6, and were positive for SEMDJL, with some clinical variability. They were also described in {PMID28229453:Ranza et al., 2017}
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.513_520del
r.(?)
p.(Glu174Alafs*266)
frameshift
deletion
Unknown
-
pathogenic
g.1168171_1168178del
-
-
-
B3GALT6_000011
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
The technique used was the custom NGS Gene panel.
-
-
United States
USA
-
-
-
-
1
Sofie Symoens
+/+
1
c.513_520del
r.(?)
p.(Glu174Alafs*266)
frameshift
deletion
Unknown
-
pathogenic
g.1168171_1168178del
-
-
-
B3GALT6_000011
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
-
-
-
Netherlands
Dutch
-
-
-
-
1
Sofie Symoens
+/+
1
c.513_520del
r.(?)
p.(Glu174Alafs*266)
frameshift
deletion
Unknown
-
pathogenic
g.1168171_1168178del
-
-
-
B3GALT6_000011
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
A non-consanguineous couple of Caucasian origin had two pregnancies terminated because of severe skeletal dysplasia. The second pregnancy was assigned the Patient ID AN_005849.The technique used was whole exome sequencing.
-
-
Netherlands
Dutch
-
-
-
-
1
Sofie Symoens
-?/.
-
c.515C>T
r.(?)
p.(Ala172Val)
-
-
Unknown
-
likely benign
g.1168173C>T
g.1232793C>T
B3GALT6(NM_080605.4):c.515C>T (p.A172V)
-
B3GALT6_000043
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-?/.
-
c.515C>T
r.(?)
p.(Ala172Val)
-
-
Unknown
-
likely benign
g.1168173C>T
g.1232793C>T
B3GALT6(NM_080605.4):c.515C>T (p.A172V)
-
B3GALT6_000043
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-?/.
-
c.519C>T
r.(?)
p.(Arg173=)
-
-
Unknown
-
likely benign
g.1168177C>T
g.1232797C>T
B3GALT6(NM_080605.4):c.519C>T (p.R173=)
-
B3GALT6_000054
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-/.
-
c.522G>C
r.(?)
p.(Glu174Asp)
-
-
Unknown
-
benign
g.1168180G>C
g.1232800G>C
B3GALT6(NM_080605.4):c.522G>C (p.E174D)
-
B3GALT6_000044
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
1
c.536_541dup
r.(?)
p.(Arg179_Arg180dup)
duplication
duplication
Both (homozygous)
-
pathogenic
g.1168194_1168199dup
-
-
-
B3GALT6_000025
-
PubMed: Alazami et al., 2016
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
EDS, EDSSPD2
Family 9
PubMed: Alazami et al., 2016
The formal ID for this family is 12DG2007.The technique used was whole exome sequencing.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+/.
-
c.536_541dup
r.(?)
p.(Arg179_Arg180dup)
-
-
Both (homozygous)
-
pathogenic (recessive)
g.1168194_1168199dup
g.1232814_1232819dup
NM_080605.3:c.536_541dupGCCGCC:p.(Arg179_Arg180dup)
-
B3GALT6_000025
-
PubMed: Maddirevula 2018
-
-
Germline
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
WES
skeletal dysplasia
12DG2007
PubMed: Maddirevula 2018
isolated case
F
yes
-
Arab
-
-
-
-
1
LOVD
-?/.
-
c.540C>A
r.(?)
p.(Arg180=)
-
-
Unknown
-
likely benign
g.1168198C>A
g.1232818C>A
B3GALT6(NM_080605.4):c.540C>A (p.R180=)
-
B3GALT6_000055
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
1
c.545A>G
r.(?)
p.(Tyr182Cys)
missense
substitution
Both (homozygous)
-
pathogenic
g.1168203A>G
-
-
-
B3GALT6_000019
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
-
-
-
Iran
Iranian
-
-
-
-
1
Sofie Symoens
+/+
1
c.556T>C
r.(?)
p.(Phe186Leu)
missense
substitution
Both (homozygous)
-
pathogenic
g.1168214T>C
-
-
-
B3GALT6_000023
-
PubMed: Alazami et al., 2016
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
EDS, EDSSPD2
Family 6
PubMed: Alazami et al., 2016
The proband has an affected cousin.The formal ID for this family is 12DG0715.The technique used was whole exome sequencing.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.556T>C
r.(?)
p.(Phe186Leu)
missense
substitution
Both (homozygous)
-
pathogenic
g.1168214T>C
-
-
-
B3GALT6_000023
-
PubMed: Alazami et al., 2016
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
EDS, EDSSPD2
Family 7
PubMed: Alazami et al., 2016
There are two affected individuals in this family.The formal ID for this family is 12DG1291.The technique used was whole genome sequencing.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.556T>C
r.(?)
p.(Phe186Leu)
missense
substitution
Both (homozygous)
-
pathogenic
g.1168214T>C
-
-
-
B3GALT6_000023
-
PubMed: Alazami et al., 2016
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
EDS, EDSSPD2
Family 8
PubMed: Alazami et al., 2016
The formal ID for this family is 12DG2397.The technique used was whole genome sequencing.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+/.
-
c.556T>C
r.(?)
p.(Phe186Leu)
-
-
Both (homozygous)
-
pathogenic (recessive)
g.1168214T>C
g.1232834T>C
NM_080605.3:c.556T>C:p.(Phe186Leu)
-
B3GALT6_000023
-
PubMed: Maddirevula 2018
-
-
Germline
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
WES
skeletal dysplasia
12DG0715
PubMed: Maddirevula 2018
isolated case
F
yes
-
Arab
-
-
-
-
1
LOVD
+/.
-
c.556T>C
r.(?)
p.(Phe186Leu)
-
-
Both (homozygous)
-
pathogenic (recessive)
g.1168214T>C
g.1232834T>C
NM_080605.3:c.556T>C:p.(Phe186Leu)
-
B3GALT6_000023
-
PubMed: Maddirevula 2018
-
-
Germline
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
WES
skeletal dysplasia
12DG1291, 12DG1024
PubMed: Maddirevula 2018
family, 2 affected (F, M)
F;M
yes
-
Arab
-
-
-
-
2
LOVD
+/.
-
c.556T>C
r.(?)
p.(Phe186Leu)
-
-
Both (homozygous)
-
pathogenic (recessive)
g.1168214T>C
g.1232834T>C
NM_080605.3:c.556T>C:p.(Phe186Leu)
-
B3GALT6_000023
-
PubMed: Maddirevula 2018
-
-
Germline
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
WES
skeletal dysplasia
12DG2397
PubMed: Maddirevula 2018
family
F
yes
-
Arab
-
-
-
-
1
LOVD
+/.
-
c.556T>C
r.(?)
p.(Phe186Leu)
-
-
Both (homozygous)
-
pathogenic (recessive)
g.1168214T>C
g.1232834T>C
NM_080605.3:c.556T>C:p.(Phe186Leu)
-
B3GALT6_000023
-
PubMed: Maddirevula 2018
-
-
Germline
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
WES
skeletal dysplasia
12DG1024
PubMed: Maddirevula 2018
family
F
yes
-
Arab
-
-
-
-
1
LOVD
+/+
1
c.588del
r.(?)
p.(Arg197Alafs∗81)
nonsense
deletion
Parent #1
-
pathogenic
g.1168246del
-
-
-
B3GALT6_000006
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
EDS, EDSSPD1
P10
PubMed: Nakajima et al., 2013
P10, of family F9, has a younger female relative of the same genotype (relation not explicitly stated, probably a sister)
-
-
Italy;Canada
Italian/Canadian
-
-
-
-
1
Raymond Dalgleish
+/.
1
c.588dup
r.(?)
p.(Arg197Alafs*246)
-
-
Unknown
-
pathogenic
g.1168246dup
g.1232866dup
588dup
-
B3GALT6_000042
-
-
-
-
Germline
-
-
-
-
-
DNA
PCR
Blood
-
SEMDJL1
-
-
-
M
no
-
-
-
-
-
-
1
Cynthia Silveira
+?/.
-
c.588dup
r.(?)
p.(Arg197AlafsTer246)
-
-
Unknown
-
likely pathogenic
g.1168246dup
-
B3GALT6(NM_080605.3):c.588dup (p.(Arg197Alafs*246)), B3GALT6(NM_080605.4):c.588dupG (p.R197Afs*246)
-
B3GALT6_000042
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+?/.
-
c.588dup
r.(?)
p.(Arg197AlafsTer246)
-
-
Unknown
-
likely pathogenic
g.1168246dup
-
B3GALT6(NM_080605.3):c.588dup (p.(Arg197Alafs*246)), B3GALT6(NM_080605.4):c.588dupG (p.R197Afs*246)
-
B3GALT6_000042
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+?
1
c.618C>G
r.(?)
p.(Cys206Trp)
missense
substitution
Both (homozygous)
-
likely pathogenic
g.1168276C>G
-
-
-
B3GALT6_000039
-
PubMed: Ben-Mahmoud et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
ALGAZ
V-2
PubMed: Ben-Mahmoud et al., 2018
This family was previously described in
PubMed: Al-Gazali et al., 1999
. The proband had two siblings V-1, and V-2, who carried the same variants and phenotype. The authors of {PMID29443383:Ben-Mahmoud et al., 2018} suggest that Al-Gazali syndrome represents the more severe phenotype among B3GALT6-related diseases due to patients dying within the first few months of life.
-
-
Palestine
Palestinian
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.619G>C
r.(?)
p.(Asp207His)
missense
substitution
Both (homozygous)
-
pathogenic
g.1168277G>C
-
-
-
B3GALT6_000001
-
PubMed: Malfait et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ, arraySEQ
-
-
EDS, EDSSPD2
P1
PubMed: Malfait et al., 2013
P1 has a maternal cousin, P2, of the same genotype
-
-
Iran
-
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.619G>C
r.(?)
p.(Asp207His)
missense
substitution
Parent #2
-
pathogenic
g.1168277G>C
-
-
-
B3GALT6_000001
-
PubMed: Malfait et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
RT-PCR, SEQ
-
-
EDS, EDSSPD2
P3
PubMed: Malfait et al., 2013
Has a younger sister, P4, of the same genotype
-
-
Iran
-
-
-
-
-
1
Raymond Dalgleish
-?/.
-
c.630G>A
r.(?)
p.(Leu210=)
-
-
Unknown
-
likely benign
g.1168288G>A
g.1232908G>A
B3GALT6(NM_080605.4):c.630G>A (p.L210=)
-
B3GALT6_000045
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
1
c.631C>T
r.(?)
p.(Pro211Ser)
missense
substitution
Unknown
-
pathogenic
g.1168289C>T
-
-
-
B3GALT6_000017
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
-
-
-
India
Indian
-
-
-
-
1
Sofie Symoens
+/+
1
c.649G>A
r.(?)
p.(Gly217Ser)
missense
substitution
Both (homozygous)
-
pathogenic
g.1168307G>A
-
-
-
B3GALT6_000003
-
PubMed: Malfait et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
RT-PCR, SEQ
-
-
EDS, EDSSPD2
P5
PubMed: Malfait et al., 2013
-
-
-
Iran
-
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.694C>T
r.(?)
p.(Arg232Cys)
missense
substitution
Parent #2
-
likely pathogenic
g.1168352C>T
-
-
-
B3GALT6_000029
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
P5
PubMed: Nakajima et al., 2013
The authors predicted the c.1A>G variant would result in a 41 aa deletion due to the second ATG becoming the initiating codon. The technique used was whole exome sequencing.
-
-
Japan
Japanese
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.694C>T
r.(?)
p.(Arg232Cys)
missense
substitution
Parent #2
-
likely pathogenic
g.1168352C>T
-
-
-
B3GALT6_000029
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
Patient 1
PubMed: Nakajima et al., 2013
The patient had a sibling who was also compound heterozygous for both variants and had a similar phenotype.c.1A>G showed a decreased molecular weight ~4kD lower compared to the WT protein. The authors suggested that the translation initiation at the second ATG of the coding sequence (position c.124) would become the initiation codon, resulting in a protein change of p.Met1_Ala41del.The technique used was whole exome sequencing.
-
-
Japan
Japanese
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.694C>T
r.(?)
p.(Arg232Cys)
missense
substitution
Parent #1
-
likely pathogenic
g.1168352C>T
-
-
-
B3GALT6_000029
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
P6
PubMed: Nakajima et al., 2013
The technique used was whole exome sequencing.
-
-
Japan
Japanese
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.694C>T
r.(?)
p.(Arg232Cys)
missense
substitution
Parent #1
-
likely pathogenic
g.1168352C>T
-
-
-
B3GALT6_000029
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
P8
PubMed: Nakajima et al., 2013
-
-
-
Viet Nam
Vietnamese
-
-
-
-
1
Raymond Dalgleish
-?/.
-
c.735G>C
r.(?)
p.(Leu245=)
-
-
Unknown
-
likely benign
g.1168393G>C
g.1233013G>C
B3GALT6(NM_080605.4):c.735G>C (p.L245=)
-
B3GALT6_000056
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+?/+?
1
c.766C>T
r.(?)
p.(Arg256Trp)
missense
substitution
Paternal (confirmed)
-
likely pathogenic
g.1168424C>T
-
-
-
B3GALT6_000038
-
PubMed: Ritelli et al., 2015
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG, SEQ
-
-
SEMDJL1
Patient 1
PubMed: Ritelli et al., 2015
The patient had a younger sister who carried both variants and had a similar phenotype. The technique used was the custom NGS Gene panel.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.782G>A
r.(?)
p.(Arg261His)
missense
substitution
Unknown
-
pathogenic
g.1168440G>A
-
-
-
B3GALT6_000013
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
-
-
-
Netherlands
Dutch
-
-
-
-
1
Sofie Symoens
+/+
1
c.795A>C
r.(?)
p.(Glu265Asp)
missense
substitution
Unknown
-
pathogenic
g.1168453A>C
-
-
-
B3GALT6_000009
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
The technique used was whole exome sequencing.
-
-
United States
USA
-
-
-
-
1
Sofie Symoens
+/+
1
c.795A>C
r.(?)
p.(Glu265Asp)
missense
substitution
Paternal (confirmed)
-
pathogenic
g.1168453A>C
-
-
-
B3GALT6_000009
-
PubMed: Sellars et al., 2014
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Sellars et al., 2014
The authors have confirmed the transcript-level sequence variants that cause the amino acid substitutions.The technique used was whole exome sequencing.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.808G>A
r.(?)
p.(Gly270Ser)
missense
substitution
Unknown
-
pathogenic
g.1168466G>A
-
-
-
B3GALT6_000021
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
The technique used was the custom NGS Gene panel.
-
-
France
French
-
-
-
-
1
Sofie Symoens
?/.
-
c.818A>G
r.(?)
p.(Asn273Ser)
-
-
Unknown
-
VUS
g.1168476A>G
-
B3GALT6(NM_080605.3):c.818A>G (p.(Asn273Ser))
-
B3GALT6_000069
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-?/.
-
c.825C>T
r.(?)
p.(Tyr275=)
-
-
Unknown
-
likely benign
g.1168483C>T
-
B3GALT6(NM_080605.4):c.825C>T (p.Y275=)
-
B3GALT6_000062
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
?/.
-
c.833C>T
r.(?)
p.(Thr278Met)
-
-
Unknown
-
VUS
g.1168491C>T
g.1233111C>T
B3GALT6(NM_080605.4):c.833C>T (p.T278M)
-
B3GALT6_000057
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+?/+?
1
c.845_846delinsTA
r.(?)
p.(Ser282Ile)
missense
delins
Both (homozygous)
-
likely pathogenic
g.1168503_1168504delinsTA
-
-
-
B3GALT6_000040
-
PubMed: Ranza et al., 2017
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
Patient 7
PubMed: Ranza et al., 2017
The patient initially had no clinical diagnosis, but was classified as having SEMDJL1 after molecular screening. The technique used was whole exome sequencing.
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+?/+?
-
c.883C>T
r.(?)
p.(Arg295Cys)
missense
substitution
Unknown
ACMG
unclassified
g.1168541C>T
g.1233161C>T
-
-
B3GALT6_000066
-
PubMed: Shen et al., 2022
-
-
Germline
-
-
-
-
-
DNA
SEQ-NG-I
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+?/.
-
c.883C>T
r.(?)
p.(Arg295Cys)
missense
substitution
Maternal (confirmed)
ACMG
unclassified
g.1168541C>T
g.1233161C>T
-
-
B3GALT6_000066
-
PubMed: Shen et al., 2022
-
-
Germline
-
-
-
-
-
DNA
SEQ-NG-I
Peripheral blood
-
EDSSPD
III-2
PubMed: Shen et al., 2022
-
M
no
China
-
-
-
-
-
1
Oumaima Nehaili
?/.
-
c.895C>A
r.(?)
p.(Leu299Met)
-
-
Unknown
-
VUS
g.1168553C>A
g.1233173C>A
B3GALT6(NM_080605.4):c.895C>A (p.L299M)
-
B3GALT6_000058
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+?/+?
1
c.899G>C
r.(?)
p.(Cys300Ser)
missense
substitution
Parent #2
-
likely pathogenic
g.1168557G>C
-
-
-
B3GALT6_000031
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ, SEQ-NG
-
-
SEMDJL1
P6
PubMed: Nakajima et al., 2013
The technique used was whole exome sequencing.
-
-
Japan
Japanese
-
-
-
-
1
Raymond Dalgleish
+?/+?
1
c.901_921dup
r.(?)
p.(Lys301_Arg307dup)
duplication
duplication
Maternal (confirmed)
-
likely pathogenic
g.1168559_1168579dup
-
-
-
B3GALT6_000035
-
PubMed: Trejo et al., 2017
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
SEMDJL1
IV-5
PubMed: Trejo et al., 2017
The proband also had two siblings who carried both variants in B3GALT6, and were positive for SEMDJL, with some clinical variability. They were also described in {PMID28229453:Ranza et al., 2017}
-
-
-
-
-
-
-
-
1
Raymond Dalgleish
+/+?
1
c.925T>A
r.(?)
p.(Ser309Thr)
missense
substitution
Parent #2
-
likely pathogenic
g.1168583T>A
-
-
-
B3GALT6_000005
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
EDS, EDSSPD1
P9
PubMed: Nakajima et al., 2013
This patient was further described in {PMID31614862:Caraffi et al., 2019}
-
-
Italy
Italy
-
-
-
-
1
Raymond Dalgleish
+/+?
1
c.925T>A
r.(?)
p.(Ser309Thr)
missense
substitution
Parent #2
-
likely pathogenic
g.1168583T>A
-
-
-
B3GALT6_000005
-
PubMed: Nakajima et al., 2013
-
-
Unknown
-
-
-
-
-
DNA
SEQ
-
-
EDS, EDSSPD1
P10
PubMed: Nakajima et al., 2013
P10, of family F9, has a younger female relative of the same genotype (relation not explicitly stated, probably a sister)
-
-
Italy;Canada
Italian/Canadian
-
-
-
-
1
Raymond Dalgleish
+/+
1
c.925T>A
r.(?)
p.(Ser309Thr)
missense
substitution
Unknown
-
pathogenic
g.1168583T>A
-
-
-
B3GALT6_000005
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
The technique used was the custom NGS Gene panel.
-
-
United States
USA
-
-
-
-
1
Sofie Symoens
+/+
1
c.929A>G
r.(?)
p.(Tyr310Cys)
missense
substitution
Unknown
-
pathogenic
g.1168587A>G
-
-
-
B3GALT6_000010
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
SEQ-NG
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
The technique used was whole exome sequencing.
-
-
United States
USA
-
-
-
-
1
Sofie Symoens
-?/.
-
c.930C>T
r.(?)
p.(Tyr310=)
-
-
Unknown
-
likely benign
g.1168588C>T
-
B3GALT6(NM_080605.4):c.930C>T (p.Y310=)
-
B3GALT6_000068
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+/+
1
c.953C>T
r.(?)
p.(Pro318Leu)
missense
substitution
Unknown
-
pathogenic
g.1168611C>T
-
-
-
B3GALT6_000015
-
PubMed: Van Damme et al., 2018
-
-
Unknown
-
-
-
-
-
DNA
PCR, SEQ
-
-
EDS, EDSSPD2
-
PubMed: Van Damme et al., 2018
This patient (PIV:1) has two affected siblings with IDs AN_005842 and AN_005843.
-
-
Congo;Rwanda
Congolese-Rwandan
-
-
-
-
1
Sofie Symoens
10 per page
25 per page
50 per page
100 per page
250 per page
500 per page
1000 per page
Legend
How to query
« First
Prev
1
2
Next
Last »
Powered by
LOVD v.3.0
Build 29
LOVD software ©2004-2023
Leiden University Medical Center